RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 98 filers reported holding RELMADA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $549,830 | +1310.0% | 118,243 | +809.7% | 0.00% | – |
Q3 2023 | $38,994 | -90.2% | 12,998 | -92.0% | 0.00% | – |
Q2 2023 | $399,374 | -11.6% | 162,347 | -18.8% | 0.00% | – |
Q1 2023 | $451,602 | -50.6% | 199,824 | -23.6% | 0.00% | – |
Q4 2022 | $913,365 | +34484.1% | 261,709 | +266.8% | 0.00% | -100.0% |
Q3 2022 | $2,641 | -24.5% | 71,347 | -61.3% | 0.00% | 0.0% |
Q2 2022 | $3,498 | -99.6% | 184,174 | +528.8% | 0.00% | – |
Q1 2022 | $791,000 | -58.3% | 29,291 | -65.2% | 0.00% | – |
Q4 2021 | $1,899,000 | -15.9% | 84,288 | -2.1% | 0.00% | – |
Q3 2021 | $2,257,000 | +252.1% | 86,082 | +329.4% | 0.00% | – |
Q2 2021 | $641,000 | -21.8% | 20,045 | -13.9% | 0.00% | – |
Q1 2021 | $820,000 | +81.4% | 23,284 | +65.3% | 0.00% | – |
Q4 2020 | $452,000 | -87.5% | 14,085 | -86.7% | 0.00% | -100.0% |
Q1 2020 | $3,624,000 | +1617.5% | 106,245 | +1862.8% | 0.00% | – |
Q4 2019 | $211,000 | – | 5,413 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deep Track Capital, LP | 2,837,818 | $9,903,985 | 0.42% |
Sio Capital Management, LLC | 235,500 | $821,895 | 0.30% |
Sio Capital Management, LLC | 235,600 | $822,244 | 0.30% |
apricus wealth, LLC | 77,329 | $269,878 | 0.25% |
RTW INVESTMENTS, LP | 2,067,824 | $7,216,706 | 0.15% |
PARSONS CAPITAL MANAGEMENT INC/RI | 496,254 | $1,731,926 | 0.14% |
Aristides Capital LLC | 69,322 | $241,934 | 0.12% |
XTX Topco Ltd | 129,387 | $451,561 | 0.10% |
AdvisorShares Investments LLC | 81,362 | $283,953 | 0.08% |
Ikarian Capital, LLC | 65,491 | $228,563 | 0.06% |